Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 018854/0467 | |
| Pages: | 10 |
| | Recorded: | 02/05/2007 | | |
| Attorney Dkt #: | 100725-39 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
3
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/30/2007
|
Application #:
|
10309611
|
Filing Dt:
|
12/04/2002
|
|
Publication #:
|
|
Pub Dt:
|
06/17/2004
| | | | |
|
Title:
|
SOLUBLE CD83 PROTEINS AND USE THEREOF FOR THE TREATMENT OR PREVENTION OF A DISEASE OR MEDICAL CONDITION CAUSED BY DYSFUNCTION OR UNDESIRED FUNCTION OF A CELLULAR IMMUNE REPSONSE INVOLVING T CELLS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/11/2015
|
Application #:
|
10382397
|
Filing Dt:
|
03/06/2003
|
|
Publication #:
|
|
Pub Dt:
|
06/10/2004
| | | | |
|
Title:
|
NUCLEIC ACID OR RECOMBINATION EXPRESSION VECTOR ENCODING SOLUBLE FORMS OF CD83, HOST CELLS TRANSFORMED/TRANSFECTED THEREWITH AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/22/2011
|
Application #:
|
10535522
|
Filing Dt:
|
04/13/2006
|
|
Publication #:
|
|
Pub Dt:
|
07/19/2007
| | | | |
|
Title:
|
USE OF SOLUBLE FORMS OF CD83 AND NUCLEIC ACIDS ENCODING THEM FOR THE TREATMENT OR PREVENTION OF DISEASES
|
|
|
Assignee
|
|
|
|
|
| 4233 TECHNOLOGY DRIVE |
| DURHAM, NORTH CAROLINA 27704 |
|
|
Correspondence name and address
|
| |
KURT G. BRISCOE
|
| |
NORRIS MCLAUGHLIN & MARCUS, P.A.
|
| |
875 THIRD AVENUE
|
| |
18TH FLOOR
|
| |
NEW YORK, NY 10022
|
Search Results as of:
05/21/2024 10:40 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
